| 09/30/2026 4:10 PM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2026 6:25 AM | Immix Biopharma (1873835) Subject | Form FWP | |
| 09/29/2026 6:22 AM | Immix Biopharma (1873835) Filer | Form 424B5 | |
| 09/29/2026 6:00 AM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 10:36 AM | EVENTIDE ASSET MANAGEMENT, LLC (1442891) Filed by Immix Biopharma (1873835) Subject | Form SCHEDULE 13G | |
| 08/13/2026 11:46 AM | Immix Biopharma (1873835) Subject Janus Henderson Group Ltd. (1274173) Filed by | Form SCHEDULE 13G/A | |
| 08/07/2026 4:05 PM | Immix Biopharma (1873835) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/20/2026 5:05 AM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/05/2026 11:56 AM | Immix Biopharma (1873835) Subject JANUS HENDERSON GROUP PLC (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/29/2026 4:10 PM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/29/2026 4:05 PM | BUCHAN JANE (1342502) Reporting Immix Biopharma (1873835) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for IMMX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/29/2026 4:05 PM | Hsu Jason (1895035) Reporting Immix Biopharma (1873835) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | Chudnovsky Yekaterina (1979324) Reporting Immix Biopharma (1873835) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | Immix Biopharma (1873835) Issuer Rachman Ilya M (1889334) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | CHANG NANCY T (1135041) Reporting Immix Biopharma (1873835) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | Immix Biopharma (1873835) Issuer Morris Gabriel S (1889967) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | Immix Biopharma (1873835) Issuer Marquet Magda (1631486) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | Immix Biopharma (1873835) Issuer Ng Carey (1889522) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | Adams Helen C. (1488486) Reporting Immix Biopharma (1873835) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2026 4:24 PM | Immix Biopharma (1873835) Filer | Form 424B5 | |
| 05/21/2026 4:28 PM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2026 5:38 AM | Immix Biopharma (1873835) Subject | Form FWP | |
| 05/21/2026 5:04 AM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 11:38 AM | Immix Biopharma (1873835) Subject JANUS HENDERSON GROUP PLC (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/07/2026 4:17 PM | Immix Biopharma (1873835) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/04/2026 3:30 PM | Immix Biopharma (1873835) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G/A | |
| 04/06/2026 3:41 PM | Immix Biopharma (1873835) Filer | Form ARS | |
| 04/06/2026 3:37 PM | Immix Biopharma (1873835) Filer | Form DEF 14A | |
| 04/06/2026 3:39 PM | Immix Biopharma (1873835) Filer | Form DEFA14A | |
| 03/27/2026 4:28 PM | Immix Biopharma (1873835) Filer | Form 10-K/A | |
| 03/25/2026 4:23 PM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:27 PM | Immix Biopharma (1873835) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/25/2026 4:19 PM | Immix Biopharma (1873835) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:21 PM | Immix Biopharma (1873835) Filer | Form 424B5 | |
| 03/20/2026 3:25 PM | Immix Biopharma (1873835) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G | |
| 02/17/2026 1:50 PM | Immix Biopharma (1873835) Subject Saturn V Capital Management LP (1964437) Filed by | Form SCHEDULE 13G | |
| 01/22/2026 11:15 PM | Immix Biopharma (1873835) Filer | Form EFFECT | |
| 01/09/2026 4:28 PM | Immix Biopharma (1873835) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 12/11/2025 7:00 PM | CHANG NANCY T (1135041) Reporting Immix Biopharma (1873835) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/10/2025 5:47 PM | Immix Biopharma (1873835) Issuer Morris Gabriel S (1889967) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/10/2025 5:49 PM | Immix Biopharma (1873835) Issuer Rachman Ilya M (1889334) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Under 3 cents a night (Ad) Bill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night.
With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies.
No re-bills and nothing to install. At $7, the only question is whether you get around to it. Get a full year of the Instant Scanner for just $7. |
| 12/08/2025 4:30 PM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/08/2025 4:27 PM | Immix Biopharma (1873835) Filer | Form 424B5 | |
| 12/08/2025 5:10 AM | Immix Biopharma (1873835) Subject | Form FWP | |
| 12/08/2025 5:15 AM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/01/2025 11:15 PM | Immix Biopharma (1873835) Filer | Form EFFECT | |
| 11/26/2025 4:10 PM | Immix Biopharma (1873835) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |